Compare Stocks

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EMH Emerald Health Therapeutics	C$0.26 -3.8%	C$0.26	C$0.15 ▼ C$0.53	C$52.28M	N/A	644,760 shs	384,329 shs
MBX Microbix Biosystems	C$0.34 -5.6%	C$0.38	C$0.23 ▼ C$0.47	C$46.43M	0.28	72,194 shs	68,486 shs

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EMH Emerald Health Therapeutics	0.00%	0.00%	0.00%	0.00%	0.00%
MBX Microbix Biosystems	+1.43%	-1.39%	-5.33%	-17.44%	-11.25%

SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
EMH Emerald Health Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MBX Microbix Biosystems	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EMH Emerald Health Therapeutics	N/A	N/A	N/A	N/A
MBX Microbix Biosystems	3.00	Buy	N/A	N/A

Current Analyst Ratings

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EMH Emerald Health Therapeutics	C$13.02M	4.02	C$0.33 per share	0.78	C$0.40 per share	0.64
MBX Microbix Biosystems	C$22.42M	2.07	C$0.08 per share	4.13	C$0.20 per share	1.70

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EMH Emerald Health Therapeutics	N/A	-C$0.70	N/A	∞	N/A	N/A	N/A	N/A	N/A
MBX Microbix Biosystems	C$3.72M	C$0.03	11.33	∞	N/A	16.57%	14.66%	1.87%	5/9/2024 (Estimated)

Latest BOT, RAC, EMH, and MBX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/14/2024	Q1 2024	MBX Microbix Biosystems	N/A	C$0.02	+C$0.02	C$0.02	C$8.10 million	C$8.41 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
EMH Emerald Health Therapeutics	N/A	N/A	N/A	N/A	N/A
MBX Microbix Biosystems	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EMH Emerald Health Therapeutics	35.45	2.97	2.61
MBX Microbix Biosystems	24.53	8.53	5.57

Ownership

Institutional Ownership

Company	Institutional Ownership
EMH Emerald Health Therapeutics	N/A
MBX Microbix Biosystems	0.42%

Insider Ownership

Company	Insider Ownership
EMH Emerald Health Therapeutics	N/A
MBX Microbix Biosystems	14.07%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
EMH Emerald Health Therapeutics	161	205.03 million	N/A	Not Optionable
MBX Microbix Biosystems	N/A	136.55 million	N/A	Not Optionable

BOT, RAC, EMH, and MBX Headlines

Source	Headline
	Microbix Presenting at the 2024 Bloom Burton Conference finance.yahoo.com - April 11 at 9:13 AM
	Microbix Announces Annual and Special Meeting Voting Results finance.yahoo.com - April 1 at 7:42 AM
	Microbix’s Clot-Buster Drug Project Advances finance.yahoo.com - March 14 at 8:22 AM
	Bo Hollas Sells 100,000 Shares of Microbix Biosystems Inc. (TSE:MBX) Stock insidertrades.com - March 12 at 5:23 AM
	Microbix Biosystems Inc.: Microbix Unveils Test Controls for Head and Neck Cancer finanznachrichten.de - March 11 at 3:10 PM
	Stocks in play: Microbix Biosystems Inc. ca.finance.yahoo.com - March 11 at 10:10 AM
	Microbix Biosystems Inc. wsj.com - March 1 at 4:14 PM
	Microbix Announces Issuance of Stock Options finance.yahoo.com - February 26 at 10:35 AM
	Microbix Biosystems First Quarter 2024 Earnings: EPS: CA$0.018 (vs CA$0.009 loss in 1Q 2023) finance.yahoo.com - February 17 at 8:26 AM
	Microbix Biosystems Inc.: Microbix Reports Record Results for Q1 Fiscal 2024 finanznachrichten.de - February 14 at 2:04 PM
	Microbix Reports Record Results for Q1 Fiscal 2024 finance.yahoo.com - February 14 at 8:57 AM
	Microbix Schedules Release of Results for Q1 Fiscal 2024 finance.yahoo.com - February 7 at 11:29 AM
	Microbix Biosystems Inc.: Microbix Unveils Test Control for Gastric Ulcer Disease Pathogen finanznachrichten.de - February 6 at 10:26 AM
	Microbix Unveils Test Control for Gastric Ulcer Disease Pathogen finance.yahoo.com - February 6 at 10:26 AM
	Microbix Achieves Further QAPs Sales Record finance.yahoo.com - January 3 at 11:20 AM
	Microbix Biosystems Full Year 2023 Earnings: Revenues Miss Expectations finance.yahoo.com - December 22 at 10:06 AM
	Microbix Reports Results for Q4 & Full-Year Fiscal 2023 finance.yahoo.com - December 21 at 8:11 AM
	Microbix & Seegene USA Jointly Enhancing Lab Test Accuracy finance.yahoo.com - December 14 at 10:24 AM
	Microbix & BioGX Collaborate on real-time PCR Assays & Controls finance.yahoo.com - December 7 at 8:19 AM
	Microbix Presenting at Florida Capital Event Conference financialpost.com - November 17 at 7:13 AM
	Microbix Biosystems Inc.: Microbix Clot-Buster Drug Fully-Funded For Return to U.S. Market finanznachrichten.de - November 16 at 8:06 AM
	Microbix Clot-Buster Drug Fully-Funded For Return to U.S. Market finance.yahoo.com - November 16 at 8:06 AM
	Microbix & Ulisse Biomed Collaborate on HPV Controls & Assays finance.yahoo.com - November 10 at 9:19 AM
	Microbix QAPs Supporting HPV Testing in Ireland finance.yahoo.com - October 27 at 8:16 AM

Media Sentiment Over Time

Top Headlines

3 High Dividend Stocks to Replace Lower Savings Yields Ahead
April 9, 2024 9:15 AM
View 3 High Dividend Stocks to Replace Lower Savings Yields Ahead
Nio Stock Price Is On Track for Penny-Stock Status
March 21, 2024 6:05 AM
View Nio Stock Price Is On Track for Penny-Stock Status
Analysts are Bullish on These 4 Oversold Large Cap Stocks
April 1, 2024 11:37 AM
View Analysts are Bullish on These 4 Oversold Large Cap Stocks
UiPath Cuts Q1 and Raises Full Year Guidance
March 26, 2024 7:41 AM
View UiPath Cuts Q1 and Raises Full Year Guidance
PayPal Appears to Have Bottomed, is it Time to Buy?
March 22, 2024 9:11 AM
View PayPal Appears to Have Bottomed, is it Time to Buy?

All Headlines

Company Descriptions

Emerald Health Therapeutics

CVE:EMH

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

Microbix Biosystems

TSE:MBX

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial